2024
DOI: 10.5694/mja2.52209
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation: the next target for secondary prevention in coronary artery disease

Samia Kazi,
James J H Chong,
Clara K Chow

Abstract: Chow has been a speaker, panel member, or attended expert forums and received honoraria for a variety of pharmaceutical companies, including, in the past three years, Novartis, Amgen, Eli Lilly, Sandoz/Sanofi, and Novo Nordisk. Samia Kazi has been a speaker and panel member for Novo Nordisk.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 23 publications
0
0
0
Order By: Relevance